Q BioMed Inc. (QBIO)
OTCMKTS
· Delayed Price · Currency is USD
0.0005
0.00 (0.00%)
Oct 17, 2024, 4:00 PM EDT
Q BioMed Cash Flow Statement
Financials in millions USD. Fiscal year is December - November.
Millions USD. Fiscal year is Dec - Nov.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2017 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Feb '23 Feb 28, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 | Nov '20 Nov 30, 2020 | Nov '19 Nov 30, 2019 | Nov '18 Nov 30, 2018 | 2017 - 2014 |
Net Income | -0.49 | -2.05 | -8.24 | -13.49 | -10.28 | -9.27 | Upgrade
|
Depreciation & Amortization | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | - | Upgrade
|
Other Amortization | 0.77 | 0.92 | 0.41 | 0.14 | 1 | 0.13 | Upgrade
|
Stock-Based Compensation | 0.77 | 0.9 | 2.34 | 6.57 | 2.5 | 2.65 | Upgrade
|
Other Operating Activities | -0.36 | 0.37 | 0.35 | 0.18 | 0.93 | 0.09 | Upgrade
|
Change in Accounts Receivable | 0.03 | 0.07 | -0.08 | -0.09 | - | - | Upgrade
|
Change in Accounts Payable | 1.19 | 1.47 | 0.84 | 0.57 | 1.41 | -0.07 | Upgrade
|
Change in Other Net Operating Assets | 0.23 | 0.21 | 0.04 | -0.16 | 0.29 | 0.02 | Upgrade
|
Operating Cash Flow | 2.18 | 1.94 | -4.3 | -6.23 | -4.11 | -6.45 | Upgrade
|
Sale (Purchase) of Intangibles | - | - | - | - | - | -0.5 | Upgrade
|
Investment in Securities | -3.14 | -3.14 | - | - | - | - | Upgrade
|
Investing Cash Flow | -3.14 | -3.14 | - | - | - | -0.5 | Upgrade
|
Short-Term Debt Issued | - | 0.65 | 3.49 | 1.97 | - | - | Upgrade
|
Long-Term Debt Issued | - | - | - | - | 0.97 | 3.87 | Upgrade
|
Total Debt Issued | 0.76 | 0.65 | 3.49 | 1.97 | 0.97 | 3.87 | Upgrade
|
Short-Term Debt Repaid | - | - | -0.03 | - | - | - | Upgrade
|
Total Debt Repaid | - | - | -0.03 | - | - | - | Upgrade
|
Net Debt Issued (Repaid) | 0.76 | 0.65 | 3.46 | 1.97 | 0.97 | 3.87 | Upgrade
|
Issuance of Common Stock | - | 0.1 | 1.01 | 0.32 | 0.62 | 4.95 | Upgrade
|
Other Financing Activities | 0.09 | 0.16 | - | - | - | - | Upgrade
|
Financing Cash Flow | 0.85 | 0.91 | 4.47 | 6.24 | 1.59 | 8.81 | Upgrade
|
Net Cash Flow | -0.38 | -0.29 | 0.17 | 0 | -2.51 | 1.86 | Upgrade
|
Free Cash Flow | 2.18 | 1.94 | -4.3 | -6.23 | -4.11 | -6.45 | Upgrade
|
Free Cash Flow Margin | 1041.64% | 682.75% | -2199.44% | -20778.14% | - | - | Upgrade
|
Free Cash Flow Per Share | 0.03 | 0.04 | -0.16 | -0.28 | -0.27 | -0.47 | Upgrade
|
Cash Interest Paid | - | - | 0 | - | 0.03 | - | Upgrade
|
Levered Free Cash Flow | 1.96 | 0.53 | -1.37 | -2.05 | -0.82 | -3.51 | Upgrade
|
Unlevered Free Cash Flow | 1.97 | 0.47 | -1.46 | -2.01 | -0.91 | -3.54 | Upgrade
|
Change in Net Working Capital | -2.85 | -1.67 | -0.77 | 0.42 | -1.56 | 0.05 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.